남성 요실금 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 요실금 유형별, 사용법별, 유통 채널별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Male Urinary Incontinence Market Size, Share & Trends Analysis Report By Product, By Incontinence Type (Stress Urinary Incontinence, Urge Urinary Incontinence), By Usage, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2033

US $ 5,950 ￦ 8,590,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,034,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,922,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

남성 요실금 시장 개요

남성 요실금 세계 시장 규모는 2024년 71억 달러로 평가되었습니다. 2033년에는 119억 2,000만 달러에 달할 것으로 예상되며 2025-2033 년에는 5.97%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 이러한 성장은 인구의 고령화, 전립선 관련 수술 증가, 요실금 관리에 대한 인식 증가에 기인합니다.

남성용 슬링, 인공요도괄약근, 자기자극기 등 의료기술의 발전은 환자의 결과를 개선하고 채택을 촉진하고 있습니다. 각 지역에서 임상시험의 수가 증가함에 따라 치료 접근 방식의 혁신이 더욱 강조되고 치료 파이프라인이 확대되고 있습니다. 캐나다 암협회에 따르면, 2024년에도 전립선암은 캐나다 남성의 건강상 중요한 관심사이며, 약 2만 7,900명이 새로 진단을 받아 남성에서 새로 진단되는 암의 22%를 차지할 것으로 예측됩니다.

전립선암은 주로 치료 후 발생하는 배뇨 합병증의 높은 발생률로 인해 남성 요실금 산업의 성장의 주요 원동력이 되었습니다. 전립선암 치료, 특히 근치적 전립선 절제술(전립선의 외과적 절제), 방사선 치료, 호르몬 치료는 골반저근육, 괄약근, 방광 기능의 심각한 손상과 약화를 초래할 수 있습니다. 그 결과 스트레스성 요실금, 절박성 요실금 또는 혼합형 요실금이 발생합니다. 전립선 절제술 후 요실금은 가장 흔한 합병증 중 하나로, 수술 후 수개월에서 수년 사이에 상당수의 남성이 겪게 됩니다. 마찬가지로 방사선 치료는 방광 자극, 저류 용량 감소, 비자발적 소변 누출을 유발할 수 있습니다. 전립선암 치료 후 생존율이 향상되고, 전립선암 치료 후 더 오래 사는 남성이 증가함에 따라 요실금 유병률도 증가하여 효과적인 관리 옵션에 대한 지속적인 수요가 발생하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 남성 요실금 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 시장이 해결해야 할 과제 분석
  • 시장 기회 분석
• 남성 요실금 시장 분석 툴
  • 산업 분석 - Porter의 Five Forces 분석
  • PESTEL 분석

제4장 남성 요실금 시장 : 제품별, 추정·동향 분석

• 남성 요실금 시장 : 제품 대시보드
• 남성 요실금 시장 : 제품 변동 분석
• 남성 요실금 시장 규모와 예측·동향 분석(제품별, 2021-2033년)
  • 비흡수성
  • 흡수성

제5장 남성 요실금 시장 : 요실금 유형별, 추정·동향 분석

• 남성 요실금 시장 : 요실금 유형 대시보드
• 남성 요실금 시장 : 요실금 유형 변동 분석
• 남성 요실금 시장 규모와 예측·동향 분석(요실금 유형별, 2021-2033년)
  • 복압성 요실금
  • 임박성 요실금
  • 일류성 요실금
  • 기능성 요실금
  • 혼합성 요실금

제6장 남성 요실금 시장 : 사용법별, 추정·동향 분석

• 남성 요실금 시장 : 사용법 대시보드
• 남성 요실금 시장 : 사용법변동 분석
• 남성 요실금 시장 규모와 예측·동향 분석(사용법별, 2021-2033년)
  • 재이용 가능
  • 일회용

제7장 남성 요실금 시장 : 유통 채널별, 추정·동향 분석

• 남성 요실금 시장 : 유통 채널 대시보드
• 남성 요실금 시장 : 유통 채널 변동 분석
• 남성 요실금 시장 규모와 예측·동향 분석(유통 채널별, 2021-2033년)
  • 오프라인 스토어
  • 온라인 채널

제8장 남성 요실금 시장 : 최종 용도별, 추정·동향 분석

• 남성 요실금 시장 : 최종 용도 대시보드
• 남성 요실금 시장 : 최종 용도 변동 분석
• 남성 요실금 시장 규모와 예측·동향 분석(최종 용도별, 2021-2033년)
  • 병원 및 클리닉
  • 재택치료
  • 기타

제9장 남성 요실금 시장 : 제품, 요실금 유형, 사용법, 유통 채널, 최종 용도, 지역에 의한 지역별, 추정·동향 분석

• 세계의 남성 요실금 시장 : 지역별 대시보드
• 시장 규모와 예측 동향 분석, 2021-2033년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 스웨덴
  • 노르웨이
  • 덴마크
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 호주
  • 태국
  • 한국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 사우디아라비아
  • 남아프리카공화국
  • 아랍에미리트(UAE)
  • 쿠웨이트

제10장 경쟁 구도

• 주요 시장 진출기업의 최근 동향과 영향 분석
• 기업/경쟁 분류
  • 혁신기업
• 벤더 구도
  • 주요 유통업체와 채널 파트너 리스트
  • 주요 기업의 시장 점유율 분석, 2024년
  • Essity
  • Boston Scientific Corporation
  • Kimberly-Clark Worldwide Inc.
  • Attends Healthcare Products, Inc.(Domtar Corporation)
  • ABENA
  • Ontex Healthcare
  • PAUL HARTMANN AG
  • Teleflex Incorporated
  • First Quality
  • Coloplast Corp.
  • Medline
  • BD
  • Hollister Incorporated
  • Cardinal Health

LSH

영문 목차

영문목차

Male Urinary Incontinence Market Summary

The global male urinary incontinence market size was estimated at USD 7.10 billion in 2024 and is projected to reach USD 11.92 billion by 2033, growing at a CAGR of 5.97% from 2025 to 2033. This growth is attributed to the aging population, rising incidence of prostate-related surgeries, and increasing awareness about incontinence management.

Advancements in medical technology, including male slings, artificial urinary sphincters, and magnetic stimulation devices, are improving patient outcomes and driving adoption. The growing number of clinical trials across regions further underscores innovation in treatment approaches, expanding the therapeutic pipeline. According to the Canadian Cancer Society, in 2024, prostate cancer remains a significant health concern among Canadian men, with approximately 27,900 new diagnoses, accounting for 22% of all newly diagnosed cancer cases in men.

Prostate cancer is a major driver of the male urinary incontinence industry's growth, mainly due to the high incidence of urinary complications that arise following its treatment. Prostate cancer treatments, particularly radical prostatectomy (surgical removal of the prostate gland), radiotherapy, and hormone therapy, can lead to significant damage or weakening of the pelvic floor muscles, sphincter mechanism, and bladder function. This results in stress urinary incontinence, urge incontinence, or mixed forms of incontinence. Post-prostatectomy incontinence is one of the most common complications, affecting a substantial proportion of men in the months and even years following surgery. Similarly, radiation therapy can cause bladder irritation, reduced storage capacity, and involuntary leakage. As survival rates improve and more men live longer after prostate cancer treatment, the prevalence of urinary incontinence also rises, creating sustained demand for effective management options.

Global Male Urinary Incontinence Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global male urinary incontinence market report based on product, incontinence type, usage, distribution channel, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Non-Absorbents
  • Urinary Catheters
  • Foley Catheters
  • External Catheters
  • Drainage Bags
  • External Compression Devices/Penile Clamps
  • Artificial Urinary Sphincter
  • Others
• Absorbents
  • Underwear & Briefs
  • Drip Collectors & Bed Protectors
  • Pads & Guards
• Incontinence Type Outlook (Revenue, USD Million, 2021 - 2033)
• Stress Urinary Incontinence
• Urge Urinary Incontinence
• Overflow Incontinence
• Functional Urinary Incontinence
• Mixed Urinary Incontinence
• Usage Outlook (Revenue, USD Million, 2021 - 2033)
• Reusable
• Disposable
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Offline Stores
• Online Channels
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals & Clinics
• Homecare
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Incontinence type
  • 1.1.3. Usage
  • 1.1.4. Distribution channel
  • 1.1.5. End Use
  • 1.1.6. Regional scope
  • 1.1.7. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity price analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Incontinence type outlook
  • 2.2.3. Usage outlook
  • 2.2.4. Distribution channel outlook
  • 2.2.5. End use outlook
  • 2.2.6. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Male Urinary Incontinence Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of urinary incontinence
    • 3.2.1.2. Growing geriatric population
    • 3.2.1.3. Rapid technological advancements
    • 3.2.1.4. Rise in demand for minimally invasive procedures
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Growing concerns regarding catheter associated urinary tract infection
    • 3.2.2.2. Availability of alternatives
  • 3.2.3. Market Challenge Analysis
    • 3.2.3.1. Social stigma and psychological barriers
  • 3.2.4. Market Opportunity Analysis
    • 3.2.4.1. Expansion in home healthcare
    • 3.2.4.2. Product innovation & customization
• 3.3. Male Urinary Incontinence Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Male Urinary Incontinence Market: Product Estimates & Trend Analysis

• 4.1. Male Urinary Incontinence Market: Product Dashboard
• 4.2. Male Urinary Incontinence Market: Product Movement Analysis
• 4.3. Male Urinary Incontinence Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.3.1. Non-Absorbents
    • 4.3.1.1. Non-absorbents market estimates and forecast 2021 to 2033 (USD Million)
    • 4.3.1.2. Urinary catheters
      • 4.3.1.2.1. Urinary catheters market estimates and forecast 2021 to 2033 (USD Million)
      • 4.3.1.2.2. Foley catheters
        • 4.3.1.2.2.1. Foley catheters market estimates and forecast 2021 to 2033 (USD Million)
      • 4.3.1.2.3. External catheters
        • 4.3.1.2.3.1. External catheters market estimates and forecast 2021 to 2033 (USD Million)
    • 4.3.1.3. Drainage bags
      • 4.3.1.3.1. Drainage bags market estimates and forecast 2021 to 2033 (USD Million)
    • 4.3.1.4. External compression devices/penile clamps
      • 4.3.1.4.1. External compression devices/penile clamps market estimates and forecast 2021 to 2033 (USD Million)
    • 4.3.1.5. Artificial urinary sphincter
      • 4.3.1.5.1. Artificial urinary sphincter market estimates and forecast 2021 to 2033 (USD Million)
    • 4.3.1.6. Others
      • 4.3.1.6.1. Others market estimates and forecast 2021 to 2033 (USD Million)
  • 4.3.2. Absorbents
    • 4.3.2.1. Absorbents market estimates and forecast 2021 to 2033s (USD Million)
    • 4.3.2.2. Underwear & Briefs
      • 4.3.2.2.1. Underwear & briefs market estimates and forecast 2021 to 2033 (USD Million)
    • 4.3.2.3. Drip Collectors & Bed Protectors
      • 4.3.2.3.1. Drip collectors & bed protectors market estimates and forecast 2021 to 2033 (USD Million)
    • 4.3.2.4. Pads & Guards
      • 4.3.2.4.1. Pads & guards market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Male Urinary Incontinence Market: Incontinence Type Estimates & Trend Analysis

• 5.1. Male Urinary Incontinence Market: Incontinence Type Dashboard
• 5.2. Male Urinary Incontinence Market: Incontinence Type Movement Analysis
• 5.3. Male Urinary Incontinence Market Size & Forecasts and Trend Analysis, by Incontinence Type, 2021 to 2033 (USD Million)
  • 5.3.1. Stress Urinary Incontinence
    • 5.3.1.1. Stress urinary incontinence market estimates and forecast 2021 to 2033 (USD Million)
  • 5.3.2. Urge Urinary Incontinence
    • 5.3.2.1. Urge urinary incontinence market estimates and forecast 2021 to 2033 (USD Million)
  • 5.3.3. Overflow Incontinence
    • 5.3.3.1. Overflow incontinence market estimates and forecast 2021 to 2033 (USD Million)
  • 5.3.4. Functional Urinary Incontinence
    • 5.3.4.1. Functional urinary incontinence market estimates and forecast 2021 to 2033 (USD Million
  • 5.3.5. Mixed Urinary Incontinence
    • 5.3.5.1. Mixed urinary incontinence market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Male Urinary Incontinence Market: Usage Estimates & Trend Analysis

• 6.1. Male Urinary Incontinence Market: Usage Dashboard
• 6.2. Male Urinary Incontinence Market: Usage Movement Analysis
• 6.3. Male Urinary Incontinence Market Size & Forecasts and Trend Analysis, by Usage, 2021 to 2033 (USD Million)
  • 6.3.1. Reusable
    • 6.3.1.1. Reusable market estimates and forecast 2021 to 2033 (USD Million)
  • 6.3.2. Disposable
    • 6.3.2.1. Disposable market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Male Urinary Incontinence Market: Distribution Channel Estimates & Trend Analysis

• 7.1. Male Urinary Incontinence Market: Distribution Channel Dashboard
• 7.2. Male Urinary Incontinence Market: Distribution Channel Movement Analysis
• 7.3. Male Urinary Incontinence Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 7.3.1. Offline Stores
    • 7.3.1.1. Offline stores market estimates and forecast 2021 to 2033 (USD Million)
  • 7.3.2. Online Channels
    • 7.3.2.1. Online channels market estimates and forecast 2021 to 2033 (USD Million)

Chapter 8. Male Urinary Incontinence Market: End Use Estimates & Trend Analysis

• 8.1. Male Urinary Incontinence Market: End Use Dashboard
• 8.2. Male Urinary Incontinence Market: End Use Movement Analysis
• 8.3. Male Urinary Incontinence Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 8.3.1. Hospitals & Clinics
    • 8.3.1.1. Hospitals & clinics market estimates and forecast 2021 to 2033 (USD Million)
  • 8.3.2. Homecare
    • 8.3.2.1. Homecare market estimates and forecast 2021 to 2033 (USD Million)
  • 8.3.3. Others
    • 8.3.3.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 9. Male Urinary Incontinence Market: Regional Estimates & Trend Analysis by Product, Incontinence Type, Usage, Distribution Channel, End Use, and Region

• 9.1. Global Male Urinary Incontinence Market: Regional Dashboard
• 9.2. Market Size & Forecasts Trend Analysis, 2021 to 2033
• 9.3. North America
  • 9.3.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Regulatory framework/ reimbursement structure
    • 9.3.2.3. Competitive scenario
    • 9.3.2.4. U.S. market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Regulatory framework/ reimbursement structure
    • 9.3.3.3. Competitive scenario
    • 9.3.3.4. Canada market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key country dynamics
    • 9.3.4.2. Regulatory framework/ reimbursement structure
    • 9.3.4.3. Competitive scenario
    • 9.3.4.4. Mexico market estimates and forecast, 2021 - 2033 (USD Million)
• 9.4. Europe
  • 9.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Regulatory framework/ reimbursement structure
    • 9.4.2.3. Competitive scenario
    • 9.4.2.4. UK market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Regulatory framework/ reimbursement structure
    • 9.4.3.3. Competitive scenario
    • 9.4.3.4. Germany market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Regulatory framework/ reimbursement structure
    • 9.4.4.3. Competitive scenario
    • 9.4.4.4. France market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Regulatory framework/ reimbursement structure
    • 9.4.5.3. Competitive scenario
    • 9.4.5.4. Italy market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Regulatory framework/ reimbursement structure
    • 9.4.6.3. Competitive scenario
    • 9.4.6.4. Spain market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Regulatory framework/ reimbursement structure
    • 9.4.7.3. Competitive scenario
    • 9.4.7.4. Sweden market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.4.8. Norway
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Regulatory framework/ reimbursement structure
    • 9.4.8.3. Competitive scenario
    • 9.4.8.4. Norway market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.4.9. Denmark
    • 9.4.9.1. Key country dynamics
    • 9.4.9.2. Regulatory framework/ reimbursement structure
    • 9.4.9.3. Competitive scenario
    • 9.4.9.4. Denmark market estimates and forecast, 2021 - 2033 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 9.5.2. China
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework/ reimbursement structure
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. China market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.5.3. Japan
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework/ reimbursement structure
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. Japan market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory framework/ reimbursement structure
    • 9.5.4.3. Competitive scenario
    • 9.5.4.4. India market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.5.5. Australia
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Regulatory framework/ reimbursement structure
    • 9.5.5.3. Competitive scenario
    • 9.5.5.4. Australia market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Regulatory framework/ reimbursement structure
    • 9.5.6.3. Competitive scenario
    • 9.5.6.4. Thailand market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.5.7. South Korea
    • 9.5.7.1. Key country dynamics
    • 9.5.7.2. Regulatory framework/ reimbursement structure
    • 9.5.7.3. Competitive scenario
    • 9.5.7.4. South Korea market estimates and forecast, 2021 - 2033 (USD Million)
• 9.6. Latin America
  • 9.6.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework/ reimbursement structure
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Brazil market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Regulatory framework/ reimbursement structure
    • 9.6.3.3. Competitive scenario
    • 9.6.3.4. Argentina market estimates and forecast, 2021 - 2033 (USD Million)
• 9.7. MEA
  • 9.7.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework/ reimbursement structure
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.7.3. South Africa
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework/ reimbursement structure
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. South Africa market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory framework/ reimbursement structure
    • 9.7.4.3. Competitive scenario
    • 9.7.4.4. UAE market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key country dynamics
    • 9.7.5.2. Regulatory framework/ reimbursement structure
    • 9.7.5.3. Competitive scenario
    • 9.7.5.4. Kuwait market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
  • 10.2.1. Innovators
• 10.3. Vendor Landscape
  • 10.3.1. List of key distributors and channel partners
  • 10.3.2. Key customers
  • 10.3.3. Key company market share analysis, 2024
  • 10.3.4. Essity
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Usage benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. Boston Scientific Corporation
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Usage benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. Kimberly-Clark Worldwide Inc.
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Usage benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. Attends Healthcare Products, Inc. (Domtar Corporation)
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Usage benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. ABENA
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Usage benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. Ontex Healthcare
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Usage benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. PAUL HARTMANN AG
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Usage benchmarking
    • 10.3.10.4. Strategic initiatives
  • 10.3.11. Teleflex Incorporated
    • 10.3.11.1. Company overview
    • 10.3.11.2. Financial performance
    • 10.3.11.3. Usage benchmarking
    • 10.3.11.4. Strategic initiatives
  • 10.3.12. First Quality
    • 10.3.12.1. Company overview
    • 10.3.12.2. Financial performance
    • 10.3.12.3. Usage benchmarking
    • 10.3.12.4. Strategic initiatives
  • 10.3.13. Coloplast Corp.
    • 10.3.13.1. Company overview
    • 10.3.13.2. Financial performance
    • 10.3.13.3. Usage benchmarking
    • 10.3.13.4. Strategic initiatives
  • 10.3.14. Medline
    • 10.3.14.1. Company overview
    • 10.3.14.2. Financial performance
    • 10.3.14.3. Usage benchmarking
    • 10.3.14.4. Strategic initiatives
  • 10.3.15. BD
    • 10.3.15.1. Company overview
    • 10.3.15.2. Financial performance
    • 10.3.15.3. Usage benchmarking
    • 10.3.15.4. Strategic initiatives
  • 10.3.16. Hollister Incorporated
    • 10.3.16.1. Company overview
    • 10.3.16.2. Financial performance
    • 10.3.16.3. Usage benchmarking
    • 10.3.16.4. Strategic initiatives
  • 10.3.17. Cardinal Health
    • 10.3.17.1. Company overview
    • 10.3.17.2. Financial performance
    • 10.3.17.3. Usage benchmarking
    • 10.3.17.4. Strategic initiatives

관련자료